or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    PRTG F Portage Biotech Inc. 12.80
    CLLS B Cellectis S.A. 12.04
    TSBX F Turnstone Biologics Corp. 11.03
    ARAY F Accuray Incorporated 10.49
    NXTC D NextCure, Inc. 7.84
    LYEL C Lyell Immunopharma, Inc. 7.63
    CLDI F Calidi Biotherapeutics, Inc. 6.60
    XLO C Xilio Therapeutics, Inc. 5.93
    SNTI D Senti Biosciences, Inc. 5.41
    ALRN D Aileron Therapeutics, Inc. 5.05
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Biotechnology Tumor Medicine Biology Biopharmaceutical Cancer Immunotherapy Cell Biology Immune System Immunotherapy Stem Cell Acute Myeloid Leukemia Cell Therapy Clinical Medicine Life Sciences Non Small Cell Lung Cancer Oncogenes Treatment Of A Range Of Cancer Tumor Microenvironment Virotherapy

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 7.52
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 5.15
    CNCR D Loncar Cancer Immunotherapy ETF 3.55
    MRGR C ProShares Merger ETF 2.53
    MNA D IQ Merger Arbitrage ETF 2.51
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare BBC to CNCR Compare CNCR to MNA Compare SURI to CNCR

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 6 ALRN Aileron Therapeutics to Present at Two Upcoming Investor Conferences
        May 6 LYEL Lyell Immunopharma reports Q1 results
        May 6 LYEL Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
        May 3 ALRN Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
        May 3 ARAY Accuray Third Quarter 2024 Earnings: Misses Expectations
        May 2 NXTC NextCure GAAP EPS of -$0.61 misses by $0.15
        May 2 CLLS Cellectis announces CFO departure
        May 2 CLLS Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
        May 2 NXTC NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
        May 2 ARAY Accuray Incorporated (NASDAQ:ARAY) Q3 2024 Earnings Call Transcript
        May 2 ARAY Accuray (ARAY) Q3 Earnings Lag Estimates, Gross Margin Contracts
        May 2 ALRN Aileron reports data from Cohort 1 of Phase Ib inhaled IPF treatment trial
        May 2 ARAY Q3 2024 Accuray Inc Earnings Call
        May 2 ARAY Accuray Inc (ARAY) Q3 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...
        May 2 ARAY Accuray Incorporated (ARAY) Q3 2024 Earnings Call Transcript
        May 1 ARAY Accuray Inc (ARAY) Faces Challenges in Fiscal Q3 2024, Misses Revenue Expectations
        May 1 ARAY Accuray (ARAY) Reports Q3 Loss, Lags Revenue Estimates
        May 1 ARAY Accuray GAAP EPS of -$0.06 misses by $0.05, revenue of $101.1M misses by $12.55M
        May 1 ARAY Accuray Reports Fiscal 2024 Third Quarter Financial Results
        May 1 ALRN Aileron announces pricing of underwritten registered direct offering priced at-the-market under Nasdaq rules of up to about $40M
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Cancer Medicine Acute Myeloid Leukemia Antibodies Cancer Immunotherapy Hematologic Malignancies Immune System Immunology Tumors Of The Hematopoietic And Lymphoid Tissues Biopharmaceutical Biotechnology Carcinoma Checkpoint Inhibitor Chronic Lymphocytic Leukemia Clinical Medicine Drugs Life Sciences Lymphocytic Leukemia Lymphoma Monoclonal Antibody
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags